Skip to main content

Month: March 2022

Acceleware Announces Closing of Non-Brokered Private Placement of 10% Unsecured Convertible Debentures

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S. CALGARY, Alberta, March 24, 2022 (GLOBE NEWSWIRE) — Acceleware Ltd. (“Acceleware”) (TSXV: AXE), a Canadian clean-tech innovator of radio frequency (RF) heating technologies today announced that it has closed its non-brokered private placement of 10% unsecured convertible debentures due 2026 (the “Debentures”), for gross proceeds of $1,500,000 (the “Private Placement”). Acceleware expects its second private placement of 10% unsecured convertible debentures due 2026, which it announced via news release on March 23, 2022, to close on or before April 15, 2022. Details of the Private Placement Each Debenture matures four years after the issue date and is convertible into units of Acceleware at a conversion price of $0.80. If Acceleware subsequently sells common...

Continue reading

Victoria Gold: 2021 Fourth Quarter And Full Year 2021 Results

TORONTO, March 24, 2022 (GLOBE NEWSWIRE) — Victoria Gold Corp. (TSX-VGCX) (“Victoria” or the “Company”) is pleased to announce its fourth quarter and year ended December 31, 2021 summary financial and operating results. The Company will host a video conference call and webcast Monday, March 28th at 8:00am PST (11:00am EST) to discuss the fourth quarter and year ended December 31, 2021 consolidated results (details are provided at the end of this news release). The Company uses certain non-IFRS performance measures throughout this news release. Please refer to the “Non-IFRS Performance Measures” section of this new release for more information. All amounts are in Canadian dollars unless otherwise indicated. This release should be read in conjunction with the Company’s Financial Statements and Management’s Discussion and Analysis...

Continue reading

Angold Announces $3 Million Marketed Public Offering of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — Angold Resources Ltd. (TSXV:AAU, FRA:13L, OTCQB:AAUGF) (“Angold” or the “Company”) is pleased to announce that it has entered into an agreement with Research Capital Corporation and Canaccord Genuity Corp. as the co-lead agents and joint bookrunners (collectively, the “Agents”), in connection with a marketed public offering of units of the Company (the “Units”) for aggregate gross proceeds of up to $3,000,000 (the “Offering“) at a price of $0.14 per Unit. Each Unit shall be comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant of the Company (a “Warrant“). Each Warrant shall entitle the holder thereof...

Continue reading

StoneCo Announces Board Changes

Board refreshment actions support StoneCo’s next stage of growth GEORGETOWN, Cayman Islands, March 24, 2022 (GLOBE NEWSWIRE) — StoneCo Ltd. (Nasdaq: STNE) (“Stone” or the “Company”), a leading provider of financial services and software solutions for merchants in Brazil, today announced several Board-refreshment actions to support the next stage of the Company’s growth. To maintain its strong focus on governance and benefit from fresh perspectives on the business and marketplace, the StoneCo Board has approved the appointment of two new Directors, Conrado Engel and Pedro Zinner. Both new Directors bring extensive knowledge in financial services and the leadership of large companies in Brazil, which are critical areas to Stone’s next phase of growth. Mr. Engel, who is a former Senior Executive Vice President at Banco Santander Brasil,...

Continue reading

GitLab Announces Departure of David Hornik From Board Of Directors

SAN FRANCISCO, March 24, 2022 (GLOBE NEWSWIRE) — All-Remote – GitLab Inc. (NASDAQ: GTLB), The DevOps Platform, announced today the resignation of August Capital General Partner and Lobby Capital Founding Partner, David Hornik, from the GitLab Inc.’s Board of Directors and Audit Committee. Hornik is departing in order to increase his focus on early stage venture investing. “On behalf of the Board of Directors and the Company, I want to thank David for his guidance,” said Sid Sijbrandij, co-founder, CEO, and chair of GitLab Inc.’s Board of Directors. “David’s long-standing experience working with innovative startups and established industry leaders has been instrumental in helping GitLab scale our business and complete our initial public offering. We wish him well in his future endeavors.” “When I was first introduced to GitLab’s...

Continue reading

NIO Inc. Reports Unaudited Fourth Quarter and Full Year 2021 Financial Results

Quarterly Total Revenues reached RMB9,900.7 million (US$1,553.6 million)iQuarterly Deliveries of the ES8, the ES6 and the EC6 were 25,034 vehiclesFull Year Total Revenues reached RMB36,136.4 million (US$5,670.6 million)Full Year Deliveries of the ES8, the ES6 and the EC6 were 91,429 vehicles SHANGHAI, China, March 24, 2022 (GLOBE NEWSWIRE) — NIO Inc. (“NIO” or the “Company”) (NYSE: NIO; HKEX: 9866), a pioneer and a leading company in the premium smart electric vehicle market, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2021. Operating Highlights for the Fourth Quarter and Full Year of 2021Deliveries of vehicles were 25,034 in the fourth quarter of 2021, including 5,683 ES8s, 12,180 ES6s and 7,171 EC6s, representing an increase of 44.3% from the fourth quarter of 2020...

Continue reading

Statera Biopharma Announces Closing of $5.7 Million Underwritten Public Offering

FORT COLLINS, Colo., March 24, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced the closing of its previously announced underwritten public offering of 12,555,555 units (“Units”), at a price to the public of $0.45 per Unit for aggregate gross proceeds of approximately $5.7 million, prior to deducting underwriting discounts, commissions, and other estimated offering expenses. Each Unit consists of one share of common stock, par value $0.005 per share (the “Common Stock”), one warrant with a one-year term to purchase one share of Common Stock at an exercise price of $0.45 per share (the “One-Year Warrants”), and one warrant with a five-year...

Continue reading

Brompton Split Banc Corp. Announces Extension of Term

TORONTO, March 24, 2022 (GLOBE NEWSWIRE) — (TSX: SBC, SBC.PR.A) As a result of strong performance, Brompton Split Banc Corp. (the “Company”) is pleased to announce that the board of directors has approved an extension of the maturity date of the Class A and Preferred shares of the Company for an additional 5-year term to November 29, 2027. The reset preferred share dividend rate for the extended term will be announced at least 60 days prior to the original November 29, 2022 maturity date and will be based on market yields for preferred shares with similar terms at that time. The term extension allows Class A shareholders to continue to invest in the Canadian bank sector with an attractive distribution rate of 8.4% based on the March 22, 2022 closing price and the opportunity for capital appreciation. Canadian banks continue to...

Continue reading

Landos Biopharma Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update

Continued Progress Towards Optimizing Clinical Development Plans On Track to Initiate Phase 2b Study of Omilancor in Ulcerative Colitis Later this Year Completed Enrollment of Phase 1b Trial of NX-13 in Ulcerative Colitis and Phase 1a Trial of LABP-104 in Normal Healthy Volunteers; Top Line Results for Both Studies Expected in Mid-2022 BLACKSBURG, Va., March 24, 2022 (GLOBE NEWSWIRE) — Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced financial results for the fourth quarter and full year ended December 31, 2021, and provided a business update. “Over the past several months, we have continued to make progress on our strategic review of Landos’ programs, which has further reinforced our decision to focus on our...

Continue reading

Vasta Announces Fourth Quarter 2021 Results

SÃO PAULO, Brazil, March 24, 2022 (GLOBE NEWSWIRE) — Vasta Platform Limited (NASDAQ: VSTA) – “Vasta” or the “Company,” announces today its financial and operating results for the fourth quarter of 2021 (4Q21) ended December 31, 2021. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). HIGHLIGHTSThe Annual Contract Value (ACV) for the 2022 school year totaled R$1,000 million, which represents growth of 35% over the subscription revenue for the 2021 cycle (collected from the fourth quarter of 2020 to the third quarter of 2021). Excluding the effects from the acquisition of Plataforma de Ensino Eleva (Eleva), ACV grew 22% compared to subscription revenue for the 2021 cycle. The 2022 ACV showed a richer mix in sources of revenue, as we managed...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.